• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浸润性乳腺癌进化过程中的不同遗传途径与不同的形态学亚型相关。

Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes.

作者信息

Buerger H, Otterbach F, Simon R, Schäfer K L, Poremba C, Diallo R, Brinkschmidt C, Dockhorn-Dworniczak B, Boecker W

机构信息

Gerhard-Domagk-Institute of Pathology, University of Münster, Germany.

出版信息

J Pathol. 1999 Dec;189(4):521-6. doi: 10.1002/(SICI)1096-9896(199912)189:4<521::AID-PATH472>3.0.CO;2-B.

DOI:10.1002/(SICI)1096-9896(199912)189:4<521::AID-PATH472>3.0.CO;2-B
PMID:10629552
Abstract

Invasive breast cancer shows a wide range of morphological differentiation, associated with differences in prognosis, but as yet, the underlying genetic mechanisms cannot be accounted for. In order to establish a model of the possible progression from the different subtypes of ductal carcinoma in situ (DCIS) to invasive breast cancer, 77 selected cases of invasive breast cancer representing distinct morphological subtypes were investigated by means of comparative genomic hybridization (CGH). There was a high degree of genetic homology between tubular and tubulo-lobular carcinoma and well-differentiated DCIS, and between ductal invasive carcinoma G3 and poorly differentiated DCIS. Highly differentiated invasive breast cancers were characterized by a loss of 16q and a low average number of aberrations per case. In high-grade tumours, losses of this chromosomal region were seen with a much lower frequency in cases with evidence of an aneuploid tumour status. These data demonstrate the close genetic similarity of well-, intermediately, and poorly differentiated DCIS and distinct morphological types of invasive breast carcinoma, providing further evidence that DCIS is a direct precursor lesion of invasive breast cancer and that various evolutionary genetic pathways exist.

摘要

浸润性乳腺癌表现出广泛的形态学分化,与预后差异相关,但迄今为止,其潜在的遗传机制尚不清楚。为了建立从不同亚型的导管原位癌(DCIS)到浸润性乳腺癌可能进展的模型,通过比较基因组杂交(CGH)研究了77例代表不同形态学亚型的浸润性乳腺癌病例。管状和小管-小叶癌与高分化DCIS之间,以及导管浸润性癌G3与低分化DCIS之间存在高度的遗传同源性。高分化浸润性乳腺癌的特征是16q缺失和每例平均畸变数量低。在高级别肿瘤中,在有非整倍体肿瘤状态证据的病例中,该染色体区域缺失的频率要低得多。这些数据证明了高分化、中分化和低分化DCIS与浸润性乳腺癌不同形态学类型之间密切的遗传相似性,进一步证明DCIS是浸润性乳腺癌的直接前驱病变,并且存在各种进化遗传途径。

相似文献

1
Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes.浸润性乳腺癌进化过程中的不同遗传途径与不同的形态学亚型相关。
J Pathol. 1999 Dec;189(4):521-6. doi: 10.1002/(SICI)1096-9896(199912)189:4<521::AID-PATH472>3.0.CO;2-B.
2
Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways.乳腺导管原位癌的比较基因组杂交——多种遗传途径的证据
J Pathol. 1999 Mar;187(4):396-402. doi: 10.1002/(SICI)1096-9896(199903)187:4<396::AID-PATH286>3.0.CO;2-L.
3
Patterns of chromosomal alterations in breast ductal carcinoma in situ.乳腺导管原位癌的染色体改变模式
Clin Cancer Res. 2004 Aug 1;10(15):5160-7. doi: 10.1158/1078-0432.CCR-04-0165.
4
Chromosomal alterations associated with the transition from in situ to invasive breast cancer.与原位乳腺癌向浸润性乳腺癌转变相关的染色体改变。
Ann Surg Oncol. 2008 Sep;15(9):2519-25. doi: 10.1245/s10434-008-0051-7. Epub 2008 Jul 12.
5
Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution.乳腺导管浸润性G2和G3癌是至少两条不同遗传进化途径的终末阶段。
J Pathol. 2001 Jun;194(2):165-70. doi: 10.1002/path.875.
6
Invasive tubular carcinoma of the breast frequently is clonally related to flat epithelial atypia and low-grade ductal carcinoma in situ.乳腺浸润性小管癌通常与扁平上皮异型增生和低级别导管原位癌存在克隆相关性。
Am J Surg Pathol. 2009 Nov;33(11):1646-53. doi: 10.1097/PAS.0b013e3181adfdcf.
7
Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade.相同分化程度的乳腺原位导管病变与浸润性导管病变之间细胞周期蛋白表达的相似性。
J Pathol. 2001 Jul;194(3):327-33. doi: 10.1002/path.910.
8
Tumour markers in breast carcinoma correlate with grade rather than with invasiveness.乳腺癌中的肿瘤标志物与肿瘤分级相关,而非与侵袭性相关。
Br J Cancer. 2001 Sep 14;85(6):869-74. doi: 10.1054/bjoc.2001.1995.
9
Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast.乳腺小叶原位癌、导管原位癌及相关浸润性癌的遗传关系。
Mol Pathol. 2000 Jun;53(3):118-21. doi: 10.1136/mp.53.3.118.
10
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.女性乳腺原位癌。一项临床病理、免疫组织化学及DNA倍体研究。
APMIS Suppl. 2003(108):1-67.

引用本文的文献

1
Ductal Carcinoma in Situ: A Detailed Review of Current Practices.导管原位癌:当前诊疗实践的详细综述
Cureus. 2023 Apr 21;15(4):e37932. doi: 10.7759/cureus.37932. eCollection 2023 Apr.
2
Proliferative epithelial changes in tumour adjacent tissue in Sri Lankan women with breast carcinoma: do morphological changes support molecular models of breast carcinogenesis?斯里兰卡女性乳腺癌癌旁组织中的增殖性上皮改变:形态学改变是否支持乳腺癌发生的分子模型?
Diagn Pathol. 2022 Dec 29;17(1):97. doi: 10.1186/s13000-022-01281-w.
3
Establishment of a 3D co-culture model to investigate the role of primary fibroblasts in ductal carcinoma in situ of the breast.
建立 3D 共培养模型以研究原代成纤维细胞在乳腺导管原位癌中的作用。
Cancer Rep (Hoboken). 2023 Apr;6(4):e1771. doi: 10.1002/cnr2.1771. Epub 2022 Dec 19.
4
Phylogenetic analysis of combined lobular and ductal carcinoma of the breast.乳腺小叶和导管癌的系统发生分析。
Mol Med Rep. 2021 Oct;24(4). doi: 10.3892/mmr.2021.12357. Epub 2021 Aug 13.
5
Complete Removal of the Lesion as a Guidance in the Management of Patients with Breast Ductal Carcinoma In Situ.完全切除病灶作为乳腺导管原位癌患者管理的指导原则
Cancers (Basel). 2021 Feb 18;13(4):868. doi: 10.3390/cancers13040868.
6
Association between radiologists' and facilities' characteristics and mammography screening detection of ductal carcinoma in situ.放射科医生和医疗机构特征与乳腺导管原位癌筛查检出率的相关性研究
Breast Cancer Res Treat. 2021 May;187(1):255-266. doi: 10.1007/s10549-020-06057-8. Epub 2021 Jan 4.
7
A qualitative transcriptional signature to reclassify histological grade of ER-positive breast cancer patients.一种用于重新分类 ER 阳性乳腺癌患者组织学分级的转录特征。
BMC Genomics. 2020 Apr 6;21(1):283. doi: 10.1186/s12864-020-6659-0.
8
Identification of a gene signature for different stages of breast cancer development that could be used for early diagnosis and specific therapy.鉴定一种可用于乳腺癌不同发展阶段早期诊断和特异性治疗的基因特征。
Oncotarget. 2018 Dec 21;9(100):37407-37420. doi: 10.18632/oncotarget.26448.
9
Triple-negative and HER2 positive ductal carcinoma in situ of the breast: characteristics, behavior, and biomarker profile.乳腺三阴性和 HER2 阳性导管原位癌:特征、行为和生物标志物特征。
Virchows Arch. 2018 Sep;473(3):275-283. doi: 10.1007/s00428-018-2416-z. Epub 2018 Jul 23.
10
Lobular Carcinoma In Situ.小叶原位癌
Surg Pathol Clin. 2018 Mar;11(1):123-145. doi: 10.1016/j.path.2017.09.009. Epub 2017 Dec 8.